Drug intelligence / Profile preview

4-[3-methylsulfanylanilino]-6,7-dimethoxyquinazoline

Development stage
Unknown
Modality
Small Molecules
01

Overview

4-[3-methylsulfanylanilino]-6,7-dimethoxyquinazoline is a synthetic small molecule belonging to the quinazoline class. It has been studied primarily as a chemical probe and research compound rather than as an approved pharmaceutical drug. The compound exhibits potential biological activities including anticancer, anti-inflammatory, and antimicrobial effects in preclinical studies. Its mechanism of action is not fully characterized but may involve inhibition of protein kinases due to its structural similarity to other quinazoline derivatives known for kinase inhibition[1][4]. There are no approved medical indications or clinical trials reported for this molecule.

Other names
6,7-dimethoxy-N-[3-(methylsulfanyl)phenyl]quinazolin-4-amine4-(3-Methylsulfanylanilino)-6,7-Dimethoxyquinazoline6,7-dimethoxy-N-(3-(methylsulfanyl)phenyl)quinazolin-4-amine
02

Targets

CDK2 (Cyclin-dependent kinase 2)RK (Ribokinase)

Beyond the preview

Go deeper on 4-[3-methylsulfanylanilino]-6,7-dimethoxyquinazoline.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 4-[3-methylsulfanylanilino]-6,7-dimethoxyquinazoline.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call